BETHANY GATES: Open Payments
NPI 1457347148 · AUGUSTA, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 39 payments from 11 companies in 2025. Trend: 2023 $1,810 · 2024 $768 · 2025 $1,045
Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 8 | $287 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $199 |
| Janssen Biotech, Inc. | 3 | $157 |
| Gilead Sciences, Inc. | 4 | $91 |
| ABBVIE INC. | 4 | $86 |
| Ipsen Biopharmaceuticals, Inc | 2 | $61 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Novo Nordisk Inc | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Ardelyx, Inc. | 1 | $21 |
Products named: REZDIFFRA, ENTYVIO, TREMFYA, RINVOQ, IQIRVO, DUPIXENT, Wegovy, GATTEX.
Industry payments across ME — which companies pay providers there.
